Sabra Healthcare REIT Inc [SBRA] stock is trading at $13.46, down -1.03%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The SBRA shares have lost -2.32% over the last week, with a monthly amount drifted -5.08%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Sabra Healthcare REIT Inc [NASDAQ: SBRA] stock has seen the most recent analyst activity on January 30, 2024, when Deutsche Bank initiated its Buy rating and assigned the stock a price target of $21. Previously, BMO Capital Markets downgraded its rating to Market Perform on October 17, 2023, and kept the price target unchanged to $16. On October 16, 2023, upgrade upgraded it’s rating to Equal Weight and revised its price target to $15 on the stock. BofA Securities upgraded its rating to a Buy and increased its price target to $16 on October 10, 2023. Wedbush initiated its recommendation with a Outperform and recommended $16 as its price target on October 03, 2023. Jefferies upgraded its rating to Buy for this stock on September 20, 2023, and upped its price target to $15. In a note dated August 11, 2023, BofA Securities upgraded an Neutral rating on this stock and boosted its target price from $11 to $14.
Sabra Healthcare REIT Inc [SBRA] stock has fluctuated between $10.10 and $14.91 over the past year. Currently, Wall Street analysts expect the stock to reach $17 within the next 12 months. Sabra Healthcare REIT Inc [NASDAQ: SBRA] shares were valued at $13.46 at the most recent close of the market. An investor can expect a potential return of 26.3% based on the average SBRA price forecast.
Analyzing the SBRA fundamentals
Sabra Healthcare REIT Inc [NASDAQ:SBRA] reported sales of 653.85M for the trailing twelve months, which represents a growth of 11.92%. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at 0.5%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.02%. To continue investigating profitability, this company’s Return on Assets is posted at 0.0, Equity is 0.0 and Total Capital is 0.06. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.86.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 13.37 points at the first support level, and at 13.29 for the second support level. However, for the 1st resistance point, the stock is sitting at 13.63, and for the 2nd resistance point, it is at 13.81.
Ratios To Look Out For
Considering the valuation of this stock, the price to sales ratio is 4.77, the price to book ratio is 1.11 and price to earnings (TTM) ratio is 230.48.
Transactions by insiders
Recent insider trading involved Costa Michael Lourenco, Executive VP, CFO & Secretary, that happened on Sep 01 ’23 when 1947.0 shares were purchased.
